Bovine leukaemia virus (BLV) resides in infected lymphocytes in a latent, repressed state but becomes expressed a few hours after the cells are cultured in vitro. We have identified several conditions and factors affecting the expression of BLV in short-term cultures of naturally infected lymphoid cells. The presence of foetal calf serum in the culture medium greatly stimulates virus expression. This stimulation is not due to cellular proliferation. Transcription of BLV RNA and synthesis of p25 in the cultures of peripheral blood lymphocytes are preceded by a lag period of several hours. Synthesis of BLV p25 in these cultures takes place almost immediately after viral RNA synthesis. Extending previous results, we demonstrate that the plasma and lymphatic fluid of cattle contain factors that suppress and stimulate BLV expression. As a result of systematic examination of several parameters, we have developed reproducible assays for the detection of these factors. It is very likely that their relative concentration in the host is an important determinant of susceptibility and resistance to the development of lymphosarcoma and persistent lymphocytosis in BLVinfected cattle.
Introduction
Bovine leukaemia virus (BLV), a C-type retrovirus, is the causative agent of enzootic bovine lymphosarcoma, a fatal neoplastic disease, and of persistent lymphocytosis (PL), an apparently benign condition which is commonly seen in dairy cattle Ferrer, 1980) . PL is characterized by a marked increase in the percentage of BLV-infected B lymphocytes in blood (Esteban et al., 1985) . Based on studies of well characterized cattle populations, it has been estimated that less than 10% of BLV-infected cattle develop lymphosarcoma and about 30% develop PL. Thus, the large majority of BLV-infected cattle are asymptomatic virus carriers. In cattle, BLV is predominantly or exclusively B cell tropic, and BLV-infected B lymphocytes account for most of the increased peripheral blood lymphocytes (PBLs) seen in cattle with PL (Esteban et al., 1985) .
BLV and the human (HTLV-I, HTLV-II) and simian (STLV-I) T cell lymphoma viruses share several important features which differentiate them from other known C-type retroviruses. One of these features is the presence in the viral genome of a coding region, known as pX, which encodes trans-activating proteins. These proteins regulate viral transcription and are believed to play an important role in the pathogenicity of the viruses (for reviews, see Yoshida, 1987; Schupbach, 1989; Nerukar 0001-0816 O 1992 SGM et al., 1990 . We have recently found that BLV, HTLV-I, HTLV-II and STLV-I share an epitope(s) which also sets them apart from other C-type, D-type and lentiretroviruses (Zandomeni et al., 1991) .
Another important characteristic shared by BLV and HTLV-I is that, m vivo, these viruses are usually present in the infected cells in a latent state (Stock & Ferrer, 1972; Baliga & Ferrer, 1977; Ferrer et al., 1980 , Gupta & Ferrer, 1982 Kettmann et al., 1982; Wong-Staal & Gallo, 1985) . The synthesis of readily detectable amounts of BLV RNA, viral proteins and viral particles can be induced or enhanced consistently and abundantly by simply culturing PBLs in vitro for a few hours (Stock & Ferrer, 1972; Baliga & Ferrer, 1977; Ferrer et al., 1980; Gupta & Ferrer, 1982) . Owing to this and other features, the BLV system is exceptionally well suited for studying the control of retrovirus expression in the natural target cells. The expression of HTLV-I can also be induced by culturing the naturally infected lymphoid cells but, as compared with the BLV system, this occurs less consistently and after longer periods of cultivation (Tochikura et al., 1985) .
Previous studies have shown that the expression of BLV in short-term cultures of bovine PBLs is blocked when these cells are cultured in 100% plasma of BLVinfected cattle (Gupta & Ferrer, 1982) . This observation has been confirmed by other investigators working with plasma of naturally infected cattle (Tsukiyama, 1985) and experimentally infected sheep (Cornil & Levy, 1989) . Preliminary data suggested that the plasma BLV blocking factor(s) (PBB) present in bovine plasma is neither an antibody nor an interferon molecule (Gupta & Ferrer, 1982; Gupta et aL, 1984) . It seems likely that PBB accounts for the repressed state in which BLV is present in vivo. PBB or PBB-like factors could be responsible for maintaining the latent state of HTLV-I and other retroviruses in vivo. Plasma from HTLV-I-infected people has been shown to inhibit the expression of HTLV-I in short-term cultures of naturally infected lymphocytes (Haynes et al., 1983; Tochikura et al., 1985) .
The study of host factors that suppress and stimulate the expression of retroviruses is of paramount importance for understanding the biology and pathogenesis of these viruses. A major stumbling block in our attempt to purify PBB has been the lack of a sensitive and quantitative assay. As a first step toward the development of such an assay, we have examined with more detail the conditions, mechanism and characteristics of BLV expression in short-term cultures of PBLs. The information obtained has enabled us to improve greatly the reproducibility of our assay to detect PBB. Using this assay, it is possible to detect them more consistently in plasma and lymphatic fluid (LF) of cattle. Our study shows that these fluids also contain a factor(s) that strongly stimulates viral expression.
Methods
Animals. The cattle used belong to a high-incidence lymphosarcoma herd, designated BF, which has been carefully characterized in terms of BLV infection, PL and lympbosarcoma risk (A'Ef'~t al., 1976; Piper et al., 1979; Gupta & Ferrer, 1981) .
Collection of plasma and lymph. Blood was extracted from cattle by venipuncture with heparin (5 units/ml) and the plasma separated by centrifugation (600 g, 15 min). The plasma was centrifuged at 40000 g for 1 h to remove platelets. Lymph was obtained with heparin (5 units/ml) by cannulating the thoracic duct according to a published procedure (Donawick et al., 1970) . The supernatant (LF) was stored at 4 °C or frozen at -70 °C until used.
Isolation of PBLs. The blood was collected using acid citrate dextrose (ACD)-EDTA as the anticoagulant, and maintained at 25 to 33 °C throughout the procedure in order to minimize viral activation. The buffy coat obtained by centrifuging the blood at 600 g for 20 min was resuspended in 3 volumes of MEM containing ACD-EDTA, and PBLs were separated from neutrophils, eosinophils and remaining red blood cells by centrifugation (1000 g for 30 min) through an Isolymph (Gallard-Schlessinger Chemical Manufacturing Corporation)-Lympholyte M (Cedadane Laboratories) gradient. The cells at the interface were suspended in MEM containing 20% autologous plasma and ACD-EDTA, and centrifuged at 100 g for 5 rain. The resulting cell pellet was washed with MEM containing 10% autologous plasma and then with MEM containing BSA (10 mg/ml) and heparin (5 units/ml). After centrifugation, the PBLs were resuspended with MEM containing BSA (10 mg/ml) and heparin (5 units/ml), and counted. Cell viability was determined using acridine orange ethidium bromide solution (Lee et al., 1975) .
Cultivation ofPBLs. PBLs were suspended in MEM containing 10% foetal calf serum (FCS) and incubated for 20 to 24 h at 37 °C in rotating polypropylene conical tubes. The conditions and survival of the PBLs were monitored after 4 h and at the end of culture. At this time, the PBLs were harvested by centrifugation at 250 g for 10 min at room temperature. The cell pellet was washed twice by centrifugation and resuspension in MEM containing beparin (5 units/ml). The cell pellet from the last centrifugation was resuspended in a hypotonic buffer (20 mM-Tris-HC1 pH 7.5, 20 mM-NaC1 and 1 mM-EDTA) (1 x 107 ceUs/ml) and mixed thoroughly. The PBLs were then lysed by adding an equal volume of lysis buffer (2 mM-Tris-HCl pH 7.5, 1 mM-EDTA, 80 mMNaC1, 1% NP40 and 0-2% sodium deoxycholate). The resulting cell extracts were frozen and thawed three times, centrifuged (12000 g for 2 min) and stored at -20 °C. Total protein concentration in the extracts was determined as described (Bradford, 1976) using BSA as the standard.
Detection of the major core BLV protein (p25) in cell extracts. The synthesis of the major core BLV protein p25 was used as an indicator of viral expression. The protein was detected in the cell extracts using the Western blot (WB) technique and the competitive radioimmunoassay (CRIA). WBs were performed essentially as described by Johnson et al. (1984) . In brief, PBL extract (80 Ixg of total protein) was mixed with Laemmli's sample buffer; the mixture was heated at 100 °C for 2 min and loaded in a 10% polyacrylamide-SDS gel as described by Laemmli (1970) . Electrophoretically separated proteins were transferred to a nitrocellulose membrane using a Bio-Rad transblot apparatus. The membranes were washed three times for 30 min in MTBS buffer (5% non-fat dry milk, 0.05% Tween 20, and 0-01% antifoam-A emulsion in PBS) and incubated for 1 h at 37 °C with a reference BLV serum appropriately diluted (McDonald & Ferrer, 1976) . The filter was washed four times with PBS containing 0.05 % Twean 20 for 30 min and binding of the serum was detected using horseradish peroxidaselabelled rabbit anti-bovine IgG (Jackson Immunoresearch Laboratories). The reference BLV sera, designated 27-125 and Se-400, were collected from BLV-infected cattle with lymphosarcoma. The characteristics of 27-125 have been described (McDonald & Ferret, 1976) . Like 27-125, Se-400 has high titres of antibodies to BLV p25.
The CRIA was performed essentially as described by McDonald & Ferret (1976) using serum 27-125. The assay was initiated with a dilution of serum 27-125 capable of binding approximately 50% of labelled BLV p25. BLV p25 was purified to homogeneity by HPLC and labelled by the chloramine T method (Greenwood et al., 1963) . Each assay included a standard competition curve with a known amount of BLV p25, and the results are expressed in ng of BLV p25 per mg of total protein.
Assays for detecting blocking activity in plasma and LF. PBLs from selected cattle with PL were used as the indicator system. The PBLs were cultured in MEM supplemented with 5 to 10% FCS for 20 to 24 h as described above. Plasma and LF and fractions of these fluids were added to the cultures at the indicated concentrations. PBLs were collected after incubation and their extracts tested for BLV p25 as described above. Further details of the assay are given in Results.
Ultrafiltration ofLF. LF was ultrafiltrated using Amicon-stirred cells with either an XM100 or a YMS0 ultrafiltration membrane. The volume of LF was reduced by ultrafiltration to two-thirds of the original volume and mixed with an equal volume of MEM. The process was repeated twice and the LF retentate was restored to its original volume.
RNA protection assay. A HindIII-BamHI fragment spanning from 4120 bp to 5225 bp of the BLV genome was derived from a cloned BLV DNA . This fragment was directionally cloned into pGEM-4Z (Promega Biotec), a derivative of pSPG4 (Melton et al., 1984) that contains a multiple cloning site flanked by promoters for the SP6 and T7 bacteriophage RNA polymerases. The construct, designated pBLV-HB, was linearized with HindlII (New England BioLabs), extracted with phenol-chloroform and precipitated by ethanol. Using the construct as a template, ssRNA probes were prepared with [ct-32p]CTP (800 Ci/mmol)(Amersham) and SP6 polymerase as recommended by Promega Biotec, the supplier of the pGEM-4Z vector. After incubation at 37 °C for 1 h, 2 units of DNase I (Promega Biotec) were added and the incubation was continued at 37°C for 15 min. Diethyloxydiformate (5 lal) was added and the emulsion was vigorously agitated at 37 °C for 15 rain. The probe was chromatographed on an Elutip-R column (Schleicher & Schuell) according to manufacturer's specifications, and eluted with 1 M-NaC1.
The RNA protection assay was conducted as described by Thompson & Gillespie (1987) . PBL samples collected at various times of cultivation were centrifuged, washed once with PBS and resuspended in 5 M-guanidine thiocyanate with 0-1 M-EDTA (1 x 10 s PBLs per ml). The samples were hybridized with the labelled BLV RNA probe, digested with RNase and spotted on ME85 paper as described (Thompson & Gillespie, 1986) . The radioactivity was determined using a Packard scintillation counter.
Southern blot. High Mr DNA was isolated from PBLs as described by Marmur (1961) and digested with BamHI using the conditions specified by the enzyme suppliers (New England Biolabs). The resulting DNA fragments were separated by horizontal gel electrophoresis in 0.8% agarose, transferred to a nitrocellulose membrane and hybridized with a 32p-labelled BLV probe using the Southern blot procedure (Southern, 1975) . The probe was prepared by labelling with [ct -3 :P]dCTP containing all BLV sequences which was constructed with a cloned BLV DNA using a nick translation kit from Amersham. Hybridizations were performed at 37 °C for 16 h in a solution containing 50~ formamide, 5 × SSC, 50 mM-sodium phosphate at pH 7.0, 5 × Denhardt's solution, 100 ~tg/ml denatured salmon sperm DNA, and 3 x 106 c.p.m, of radiolabelled probe per ml of solution. The membranes were washed three times with a solution containing 2 × SSC, 0-1% SDS and 10 mM-sodium pyrophosphate at room temperature and then twice with a solution containing 0.1 x SSC, 0.1% SDS and 10 mM-sodium pyrophosphate at 50 °C for 1 h. The dried membranes were exposed to X-ray film at -70 °C using an intensifying screen.
Results

Conditions affecting the expression of BL V in short-term cultures of lymphoid cells
In previous studies we used 24 to 48 h cultures of buffy coat leukocytes (BCLs) from BLV-infected cattle as the indicator system to detect blocking activity on the expression of BLV in bovine plasma. However, subsequently we found that the amount of BLV p25 varies significantly even among buffy coat samples obtained at short intervals from the same animal. Therefore, in an attempt to develop a reproducible blocking assay, we set out to identify a satisfactory indicator cell system and examine in more detail the variables and mechanisms involved in the phenomenon of BLV expression in shortterm cultures of naturally infected cells.
We examined first the suitability, as an indicator system, of a permanent culture of neoplastic lymphoid cells derived from a cow with histologically confirmed lymphosarcoma. Under normal culture conditions this cell line, known as NBC-13, synthesizes only small amounts of BLV p25 but can be induced to synthesize the antigen in larger quantities by changing the culture conditions or after stimulation with phytohaemagglutinin (PHA) (Ferrer et al., 1971) or phorbol 12-myristate 13-acetate (G. L. Cockerell, personal communication). We found, however, that BLV expression in the NBC-13 cell line was not inhibited by preparations of LF which strongly blocked virus expression in short-term PBL cultures. This observation suggests that the mechanisms of induction of BLV expression in cultures of NBC-13 cells and of PBLs are different. On this basis, we concluded that the NBC-13 cell line does not provide a suitable indicator system to detect the blocking factor in cattle.
The induction of BLV expression was much more consistent when Ficoll Hypaque-isolated PBLs rather than BCLs were used. Extracts of cultured PBLs isolated by centrifugation on an isolymph=lympholyte-M gradient also gave more consistent curves than extracts of cultured buffy coat lymphocytes when tested for BLV p25 in the CRIA. This is probably due to the greater concentration of viral proteins relative to cellular proteins in the PBL extracts.
Preliminary observations suggested that there is a correlation between the presence of platelets in the PBL samples and the activation of BLV expression when these cells were cultured. Thus before incubation, the PBLs were washed repeatedly by centrifugation in order to reduce platelet contamination. Cell recovery and viability was improved by culturing the PBLs in rotating tubes rather than under stationary conditions. Culturing the PBLs in rotating tubes also drastically reduced cell clumping and formation of a gel-like substance which is often seen when the cells are cultured under stationary conditions.
The amount of BLV p25 synthesized in PBL cultures of cattle with PL was much greater than in PBL cultures of infected cattle with normal PBL counts. This is attributable to the fact that, as compared with infected cattle without PL, PL cattle have a larger proportion of infected PBLs (Esteban et al., 1985) . However, the yield of BLV p25 varied considerably among PBL cultures of PL cattle having comparable percentages of infected PBLs (Fig. 1) .
In most cases, little or no detectable induction of BLV p25 occurred when the PBLs were cultured in MEM without FCS. The addition of FCS to the culture medium greatly stimulated BLV p25 expression. This stimulatory effect increased with the concentration of FCS (Fig. 1) . In some experiments, relatively high levels of expression were detected in the cultures without FCS. This may result from the activation of the viral genome during collection and preparation of the PBLs. We found that, in most cases, maintaining the PBLs between 23 °C and 30 °C, reducing the time of handling and minimizing mechanical procedures during their isolation significantly reduced this background expression. Confirming previous observations, we found that the expression of BLV in PBLs is greatly enhanced by the addition of a supramitogenic dose of PHA to the culture medium. This enhancing effect was observed regardless of whether or not FCS was present in the culture medium (not shown).
During the last few years, more than 200 PBL samples from BLV-infected cattle have been tested for BLV p25 in our laboratory before and after short-term cultivation. Extending previous findings (Baliga & Ferrer, 1977; Ferrer et al., 1980; Gupta & Ferrer, 1982) , in no instance have we detected BLV p25 in the samples before cultivation. However the antigen was detected in the same samples after 20 to 48 h of cultivation in MEM supplemented with 5 to 20~ FCS.
Kinetics of BL V expression in short-term PBL cultures
The kinetics of BLV expression were studied in PBL cultures incubated in the presence of MEM supplemented with FCS. Extracts were prepared from cells obtained at 3 h intervals from parallel cultures and tested for BLV p25 by CRIA and WB. BLV p25 became detectable by CRIA after 5 to 7 h of culture and after 10 to 12 h by WB (Fig. 2) . Subsequently, BLV p25 was synthesized at a slow rate for 2 to 4 h and this was followed by a rapid increase in the synthesis of the antigen which reached a plateau at 20 to 24 h of culture.
In an attempt to gain an insight into the events taking place during the lag period, experiments were conducted with the RNA polymerase II-specific inhibitor 5,6-dichloro-1-fl-D-ribofuranosylbenzimidazole (D RB), which selectively inhibits cellular and viral transcription. The effect of this compound is rapid (3 min for 70~ inhibition), and does not affect cellular energy metabolism or mRNA translation (Tamm et al., 1984; Zandomeni et al., 1982 Zandomeni et al., , 1983 . DRB was added to PBL cultures at different times of incubation, and the cultures were continued for a total of 24 h without removing the compound. The amount of BLV p25 was determined in extracts prepared from cells obtained after 24 h of cultivation in the presence of DRB and from cells obtained from parallel cultures at the time DRB was added. As shown in Fig. 3 (a) , DRB completely inhibited viral expression when added at the beginning of the 24 h culture. When DRB was added after various periods of cultivation, the amount of BLV p25 detected at the time at which the compound was added was the same or slightly higher than that detected after completion of the 24 h cultivation period.
An RNA-RNA protection assay was used to determine directly the time course of BLV RNA synthesis in PBL cultures. RNA was solubilized from the cells in a concentrated solution of guanidine thiocyanate and hybridized directly with the 32p-labelled RNA probe. The radioactivity resistant to digestion with RNase was directly proportional to the viral RNA complementary to the probe. As shown in Fig. 3 (b) , the amount of viral RNA detected with this assay during the first 6 h of culture was only slightly above background. Like in the case of BLV p25, the amount of viral RNA increased markedly after this lag period.
Soluble factors in plasma and LF affect BL V expression in PBL cultures
The systematic study of the variables and conditions involved in the phenomenon of BLV expression in naturally infected PBLs enabled us to improve greatly the reproducibility of the assay for detection of PBBs. The rigorous selection of the cows used as donors of the indicator PBLs was found to be critical. PBLs from cattle with PL were found to be more suitable than PBLs from infected cattle without PL. The use of isolymphlympholyte M-isolated PBLs, rather than BCLs, was also important for the reproducibility of the blocking assay, as were the procedures, referred to above, that minimize platelet contamination and activation during the isolation and culture of the PBLs. The best results were obtained when plasma was tested for blocking activity at a concentration of 20 to 40% in MEM supplemented with 5 to 10% FCS, rather than at a 100% concentration as in previous studies (Gupta & Ferrer, 1982) . The use of plasma at 20 to 40% concentrations improves significantly the viability and recovery of the PBLs upon cultivation. As pointed out above, even when all precautions are taken, the indicator PBLs occasionally synthesize considerable amounts of BLV p25 upon cultivation in MEM in the absence of FCS. Unlike the expression of BLV in PBLs cultured in MEM with FCS, the background expression seen in the cultures without FCS, which is probably caused by activation of the viral genome during the collection of blood and/or isolation of the cells, was not consistently inhibited by plasma or LF.
As presently standardized, our PBB assay is based on the inhibition by PBBs of the synthesis of BLV p25 induced by the stimulatory factor(s) present in FCS. To monitor the possible activation of the BLV genome during the collection and preparation of the indicator PBLs, the assay includes as a control a culture of the indicator cells with 10 mg/ml of BSA instead of FCS. In addition, the PBLs are always tested for BLV p25 expression before cultivation. Variations were noted in the PBB activity of plasma from different cattle and, on some occasions, plasma samples taken from the same animal at different times.
Since the variability of BLV blocking activity seen with plasma could be due to factors with stimulatory activity on BLV expression released by platelets (Tsukiyama et al., 1987) or produced during collection of the blood, we reasoned that LF, which is virtually free of platelets, would provide a more suitable source of PBBs. Blocking activity was detected in the LF of the three infected cows tested. As shown by the titration experiment of Fig. 4 , the PBB activity of LF is dose-dependent and is maximum at a concentration of 3 0~ to 40~. This activity was not affected after storage of the LF at -70 °C. The results of Fig. 5 show that the blocking activity of the LF was strong at all the concentrations of FCS used (2.5 to 30~o) to stimulate viral expression.
In several experiments in which we used as the indicator system PBL samples in which 70Y/oo or more of the cells were infected, the cell recovery after 20 to 24 h of cultivation was also 7 0~ or more in both the control cultures and in the cultures in which the synthesis of BLV p25 was markedly inhibited by LF or plasma. These observations argued against the possibility that the inhibitory activity of these fluids was due to a cytotoxic effect. For a more definitive conclusion, we compared the concentration of viral D N A present in the PBL samples before cultivation and after they were cultured with or without 4 0~ LF. The indicator cells were obtained from a donor in which approximately 70 ~ of the PBLs are infected (Esteban et al., 1985) . The D N A was digested with B a m H I and examined by Southern blotting using the 3zp-labeUed cloned viral D N A as the probe. Extracts prepared from the PBL samples before and after cultivation were tested for the presence of BLV p25 by CRIA, and the number and viability of the cells were determined in all samples. As determined by the intensity of the BLV-specific bands (Fig. 6a) FCS, and in the samples of cultured PBLs in which viral expression was inhibited by the addition of LF (Fig. 6b) .
The viability and percent cell recovery (approximately 70~ in both cases) were virtually the same in these cultures. These results confirm that (i) the need to cultivate PBLs to detect BLV p25 is not due to the expansion of a subpopulation of productively infected cells, and (ii) the PBB activity of LF is not due to the selective destruction of the infected cells.
Other experiments showed that LF also strongly inhibited the synthesis of BLV p25 in PBL cultures treated with supramitogenic doses of PHA (not shown). Fig. 7 shows the results of a representative ultrafiltration experiment with the LF of an infected cow. The blocking activity was found in the high Mr (> 100 K) fraction, whereas the low Mr (< 50 K) fraction stimulated expression. The PBL cultured in the presence of the low Mr fraction contained twice as much BLV p25 as the PBLs cultured in the absence of this fraction. The stimulating activity was even stronger in the low Mr fraction of plasma. The factor(s) responsible for this activity has been tentatively designated BSF.
Experiments in which the high Mr fractions of LF or plasma were subjected to ammonium sulphate precipitations showed that the blocking activity precipitated at least partially between 20 and 33 ~ ammonium sulphate concentration.
Discussion
The present and previous studies (Stock & Ferrer, 1972; Baliga & Ferrer, 1977; Ferrer et al., 1980; Gupta & Ferrer, 1982) show that, whether neoplastic or not, in vivo lymphoid cells naturally infected with BLV harbour the virus in a repressed state, but consistently synthesize readily detectable amounts of viral RNA, viral proteins and viral particles when they are cultured for a few hours. There is no other system involving cells naturally infected with a C-type retrovirus in which viral expression can be 'turned on' as consistently and rapidly by just culturing the infected cells. Thus PBLs of naturally infected cattle provide an exceptional model system to study the regulation of the expression of retroviruses by host soluble factors. Another advantageous feature of the BLV system for these studies is the ready availability of the large volumes of fluids which are likely to be required to purify and characterize such factors fully.
In previous studies no viral RNA could be detected in uncultured PBLs of BLV-infected cattle using the dot blot (Gupta & Ferrer, 1982; Kettmann et al., 1982) , liquid hybridization (Ferrer et al., 1980; Kettmann et al., 1980) or Northern blot (Van Den Broeke et al., 1988) hybridization techniques. Based on these results, it was concluded that the blocking of BLV expression in vivo occurs at the transcriptional level. More recently, using the polymerase chain reaction (PCR), BLV mRNA encoded by the tax/rex region has been detected in uncultured PBLs of infected cattle and sheep (Jensen et al., 1991) . The possibility that this mRNA was synthesized during the isolation and handling of the PBLs before the cell extracts were prepared was not completely excluded. On the other hand, using reverse transcriptasedirected PCR, BLV RNA was detected in plasma of a BLV-infected cow (Sherman et al., 1991) . Taken together, these results suggest that the blocking of the transcription of the BLV genome in vivo is not complete or permanent. The fact that virtually all infected cattle have viral antibodies continuously (Ferrer, 1980) is evidence that viral expression takes place in vivo. Since, despite exhaustive examinations, BLV p25 has never been detected in infected PBLs before cultivation, it seems clear that if viral proteins are synthesized in vivo this occurs in a very small percentage of the infected cells, or intermittently and during only very short periods of time, or continuously at very low levels. Alternatively, it is conceivable that viral expression never occurs in the infected PBL but it does in cells located in certain tissues.
The synthesis of BLV p25 upon cultivation of the PBLs follow a biphasic curve, the first phase consisting of a lag period of several hours in which little or no synthesis of BLV p25 occurs. At the beginning of the second phase the protein is synthesized at a slow rate for 2 to 4 h and then very rapidly, reaching maximal concentration after 20 to 24 h of culture. The lag period is also observed in the PBL cultures stimulated by the addition of supramitogenic doses of PHA. In this case, however, the rapid synthesis of BLV p25 is seen 1 to 2 h earlier and the concentration of BLV p25 attained is three to five times higher (not shown). A similar lag period is observed when DRB is added at different times during the 24 h incubation of the PBLs. Since DRB inhibits only RNA polymerase II transcription and does not affect the translational machinery or the energy metabolism (Tamm et al., 1984; Zandomeni et al., 1982 Zandomeni et al., , 1983 , it appears that the synthesis of genomic mRNA also occurs after a lag period.
The results of our DRB experiments also show that the concentration of BLV p25 reached in untreated PBLs at a given time during the cultivation is almost the same as that in PBLs that are treated with DRB at this time and then incubated for a total 24 h period. Thus, it seems that translation of viral mRNA takes place immediately after transcription. This suggested pattern of transcription was confirmed when the synthesis of BLV RNA was measured directly in the PBL cultures at different times of incubation. Thus, neither genomic norgag mRNA are synthesized during the lag period in amounts detectable by the procedures used. A similar pattern of viral RNA expression was observed in lymphoid cells of sheep experimentally infected with BLV (Lagarias & Radke, 1989) . It remains to be determined whether the lag period reflects the time needed for the transduction signal to reach the transcriptional machinery or the time during which an intermediary molecule inducing the transcription of the viral genes is synthesized. In support of the second possibility is the observation that the stimulation of BLV expression by PHA involves the induction of a cellular protein (Chatterjee et al., 1985) .
Our results show that the presence of FCS greatly enhances the expression of BLV in short-term bovine PBL cultures. A similar observation has been made regarding the expression of BLV in PBLs of experimentally infected sheep (Lagarias & Radke, 1989) . The data strongly argue against the possibility that detection of BLV p25 in the PBL cultures in the presence of FCS is the result of the rapid expansion of a subpopulation of infected cells. Although viral DNA was approximately the same in the PBLs before and after 24 h of culture in the presence of FCS, BLV p25 was detected in these cells only after cultivation.
Confirming and expanding previous observations (Stock & Ferrer, 1972; Baliga & Ferrer, 1977; Chatterjee et al., 1985) , we found that supramitogenic doses of PHA stimulate both the transcription and translation of the BLV genome in PBL cultures, and that this effect does not require the presence of FCS in the culture medium.
Concavalin A, another T cell mitogen, and B cell mitogens, such as pokeweed mitogen or lipopolysaccharide, have been shown to increase BLV RNA synthesis in PBL cultures (Lagarias & Radke, 1989) , they failed to stimulate the synthesis of BLV p25 in these cultures (Driscoll et at., 1977; Chatterjee et al., 1985) . Thus, it appears that these various activators of BLV expression can act at the transcriptional and/or translational levels.
We confirm the observation that plasma of cattle have a soluble factor(s), previously designated PBB (Gupta & Ferrer, 1982) , with strong inhibitory activity on the expression of BLV p25 in PBL cultures, and show that such activity is also present in bovine lymph. The PBB activity is not due to a cytotoxic effect because the concentration of viral DNA in the PBL cultures in which viral expression was inhibited by LF was the same as that seen in the control cultures.
Unlike the expression of BLV seen in PBLs cultured in the presence of FCS, the background expression seen occasionally in PBLs cultured in medium without FCS, which is most likely due to the activation of the viral genome during the collection of blood and preparation of PBLs, is not consistently inhibited by PBB. Thus, one possible explanation for the failure of Lagarias & Radke (1989) to detect PBB activity in plasma of BLV-infected sheep could be that in their studies the viral genome was activated during the preparation of the indicator cells.
Neither LF nor plasma with a strong blocking activity on the expression of BLV in PBL cultures inhibits viral expression in chronically infected NBC-13 cell lines. This suggests that the mechanisms underlying the phenomenon of viral expression in these cultures are different. Unlike in the uncultured PBLs, in the NBC-13 cells there is always a considerable backgound expression of BLV p25. Moreover, phorbol 12-myristate 13-acetate, which strongly stimulates viral expression in NBC-13 cells (G. L. Cockerell, personal communication) does not do so significantly in PBL cultures of BLVinfected cattle (unpublished data). Conversely, the stimulatory effect on BLV expression of supramitogenic doses of PHA is strong on PBL cultures (Stock & Ferrer, 1972; Chatterjee et al., 1985) , and weak on NBC-13 cultures (Ferrer et al., 1971) .
We have detected BLV blocking activity in some plasmas of BLV-free cattle which were negative for BLV antibodies (unpublished data). On the assumption that the blocking activities of these plasmas and those from non-infected cattle are due to the same factor(s), the above observation is further evidence that PBB is not a BLV antibody. Studies comparing the frequency and level of PBB in BLV-infected vs. non-infected cattle, in cattle with PL vs. cattle without PL, and in cattle that develop lymphosarcoma vs. cattle that remain asymptomatic carriers, have been postponed until an assay more sensitive and quantiative than that now available is developed. The development of this assay will most likely require obtaining PBB in a highly purified form.
Ultrafiltration experiments showed that plasma and LF of BLV-infected cattle also contain a factor(s), designated BSF, with strong stimulatory activity on BLV expression. It is likely that previous failures to detect blocking activity in the plasma of cattle and sheep were due, at least in part, to differences in the relative concentration of the blocking and stimulating factors.
In addition to FCS, PHA and BSF, insulin-transferrin-selenium (unpublished observation) and a plateletderived factor (Tsukiyama et al., 1987) stimulate BLV expression in PBL cultures. Unlike PHA and insulintransferrin-selenium, BSF exerts its stimulatory activity on viral expression only when FCS is present in the culture medium. The relation of BSF to the stimulatory factor in FCS remains to be studied. Thus it seems that the expression of BLV in PBL cultures can be induced or enhanced by a variety of cell activators which may or may not have mitogenic activity and that may operate through different mechanisms. It has been shown that certain cytokines, growth factors and soluble antigens induce or stimulate the expression of human immunodeficiency virus (HIV) in chronically infected cell lines (Folks et al., 1987; Nabel et al., 1988) . Most likely cells infected in vivo with BLV or other retroviruses, such as HTLV-I and HIV, are often exposed to factors capable of stimulating expression of the viral genome. It seems reasonable to postulate that PBB or PBB-like factors somehow interfere with the activity of the stimulatory factors thus explaining the fact that, at least in the majority of the cells infected with these viruses, viral expression is repressed.
The identification of the optimal conditions for the stimulation and inhibition of the expression of BLV in naturally infected PBLs has enabled us to improve greatly the detection assays for PBB and BSF. The availability of these improved assays and of a procedure to separate PBB from BSF has enabled us to make steady progress in our attempts to purify and characterize these factors. The results obtained in these attempts are the subject of a separate communication. The purification and characterization of PBB and BSF should facilitate identification and purification of putative host soluble factors with stimulatory and blocking activity on the expression of HTLV-I and, perhaps, HIV.
It is conceivable that variations in the relative concentrations of the blocking and stimulating factors play a central role in determining resistance and susceptibility to the development of disease in hosts infected with BLV, HTLV-I and, perhaps, HIV.
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